Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 11 8% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC Reaffirms Buy Rating for Phathom Pharmaceuticals (NASDAQ:PHAT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Needham & Company LLC in a research note issued on Friday, Benzinga reports. They presently have a $26.00 target price on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 188.89% from the […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s stock price gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $9.73, but opened at $10.49. Phathom Pharmaceuticals shares last traded at $9.42, with a volume of 136,494 shares. The company reported ($0.80) earnings […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price was up 9.4% on Tuesday . The company traded as high as $10.65 and last traded at $10.16. Approximately 351,678 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 761,808 shares. The stock had previously closed at $9.29. […]